These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 30733525)

  • 1. Enabling precision medicine by unravelling disease pathophysiology: quantifying signal transduction pathway activity across cell and tissue types.
    van de Stolpe A; Holtzer L; van Ooijen H; Inda MA; Verhaegh W
    Sci Rep; 2019 Feb; 9(1):1603. PubMed ID: 30733525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of Functional Phosphatidylinositol 3-Kinase Pathway Activity in Cancer Tissue Using Forkhead Box-O Target Gene Expression in a Knowledge-Based Computational Model.
    van Ooijen H; Hornsveld M; Dam-de Veen C; Velter R; Dou M; Verhaegh W; Burgering B; van de Stolpe A
    Am J Pathol; 2018 Sep; 188(9):1956-1972. PubMed ID: 30030980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative Measurement of Functional Activity of the PI3K Signaling Pathway in Cancer.
    van de Stolpe A
    Cancers (Basel); 2019 Mar; 11(3):. PubMed ID: 30832253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High Efficacy of Combination Therapy Using PI3K/AKT Inhibitors with Androgen Deprivation in Prostate Cancer Preclinical Models.
    Marques RB; Aghai A; de Ridder CMA; Stuurman D; Hoeben S; Boer A; Ellston RP; Barry ST; Davies BR; Trapman J; van Weerden WM
    Eur Urol; 2015 Jun; 67(6):1177-1185. PubMed ID: 25220373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androgen Receptor Pathway Activity Assay for Sepsis Diagnosis and Prediction of Favorable Prognosis.
    Bouwman W; Verhaegh W; van de Stolpe A
    Front Med (Lausanne); 2021; 8():767145. PubMed ID: 34888328
    [No Abstract]   [Full Text] [Related]  

  • 6. ER and PI3K Pathway Activity in Primary ER Positive Breast Cancer Is Associated with Progression-Free Survival of Metastatic Patients under First-Line Tamoxifen.
    Sieuwerts AM; Inda MA; Smid M; van Ooijen H; van de Stolpe A; Martens JWM; Verhaegh WFJ
    Cancers (Basel); 2020 Mar; 12(4):. PubMed ID: 32230714
    [No Abstract]   [Full Text] [Related]  

  • 7. PI3K-AKT-mTOR pathway is dominant over androgen receptor signaling in prostate cancer cells.
    Kaarbø M; Mikkelsen OL; Malerød L; Qu S; Lobert VH; Akgul G; Halvorsen T; Maelandsmo GM; Saatcioglu F
    Cell Oncol; 2010; 32(1-2):11-27. PubMed ID: 20203370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interplay Among PI3K/AKT, PTEN/FOXO and AR Signaling in Prostate Cancer.
    Yan Y; Huang H
    Adv Exp Med Biol; 2019; 1210():319-331. PubMed ID: 31900915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockdown of the cochaperone SGTA results in the suppression of androgen and PI3K/Akt signaling and inhibition of prostate cancer cell proliferation.
    Trotta AP; Need EF; Selth LA; Chopra S; Pinnock CB; Leach DA; Coetzee GA; Butler LM; Tilley WD; Buchanan G
    Int J Cancer; 2013 Dec; 133(12):2812-23. PubMed ID: 23740762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of signaling cross-talks contributing to acquired drug resistance in breast cancer cells by Bayesian statistical modeling.
    Azad AK; Lawen A; Keith JM
    BMC Syst Biol; 2015 Jan; 9():2. PubMed ID: 25599599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of activity of developmental signal transduction pathways to quantify stem cell pluripotency and phenotypically characterize differentiated cells.
    Holtzer L; Wesseling-Rozendaal Y; Verhaegh W; van de Stolpe A
    Stem Cell Res; 2022 May; 61():102748. PubMed ID: 35325817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PSMA redirects cell survival signaling from the MAPK to the PI3K-AKT pathways to promote the progression of prostate cancer.
    Caromile LA; Dortche K; Rahman MM; Grant CL; Stoddard C; Ferrer FA; Shapiro LH
    Sci Signal; 2017 Mar; 10(470):. PubMed ID: 28292957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complex impacts of PI3K/AKT inhibitors to androgen receptor gene expression in prostate cancer cells.
    Liu L; Dong X
    PLoS One; 2014; 9(10):e108780. PubMed ID: 25360799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The molecular underpinnings of prostate cancer: impacts on management and pathology practice.
    Rodrigues DN; Boysen G; Sumanasuriya S; Seed G; Marzo AM; de Bono J
    J Pathol; 2017 Jan; 241(2):173-182. PubMed ID: 27753448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wnt/Beta-Catenin Signaling and Prostate Cancer Therapy Resistance.
    Yeh Y; Guo Q; Connelly Z; Cheng S; Yang S; Prieto-Dominguez N; Yu X
    Adv Exp Med Biol; 2019; 1210():351-378. PubMed ID: 31900917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-genomic action of resveratrol on androgen and oestrogen receptors in prostate cancer: modulation of the phosphoinositide 3-kinase pathway.
    Benitez DA; Pozo-Guisado E; Clementi M; Castellón E; Fernandez-Salguero PM
    Br J Cancer; 2007 May; 96(10):1595-604. PubMed ID: 17486135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNA Based Approaches to Profile Oncogenic Pathways From Low Quantity Samples to Drive Precision Oncology Strategies.
    van de Stolpe A; Verhaegh W; Blay JY; Ma CX; Pauwels P; Pegram M; Prenen H; De Ruysscher D; Saba NF; Slovin SF; Willard-Gallo K; Husain H
    Front Genet; 2020; 11():598118. PubMed ID: 33613616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Forkhead box transcription factor FOXO3a regulates estrogen receptor alpha expression and is repressed by the Her-2/neu/phosphatidylinositol 3-kinase/Akt signaling pathway.
    Guo S; Sonenshein GE
    Mol Cell Biol; 2004 Oct; 24(19):8681-90. PubMed ID: 15367686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oleic acid promotes prostate cancer malignant phenotype via the G protein-coupled receptor FFA1/GPR40.
    Liotti A; Cosimato V; Mirra P; Calì G; Conza D; Secondo A; Luongo G; Terracciano D; Formisano P; Beguinot F; Insabato L; Ulianich L
    J Cell Physiol; 2018 Sep; 233(9):7367-7378. PubMed ID: 29663374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.